losclouds

Lixte Biotechnology HoldingsLixte Biotechnology Holdings

Clinical-stage pharmaceutical company developing cancer therapies targeting protein phosphatases with lead compound LB-100 in trials for glioblastoma and other solid tumors, focusing on novel enzyme inhibition approaches.

About

What Lixte Biotechnology Holdings is

Clinical-stage pharmaceutical company developing cancer therapies targeting protein phosphatases with lead compound LB-100 in trials for glioblastoma and other solid tumors, focusing on novel enzyme inhibition approaches.

losclouds keeps public details for this profile. There are no catalog offerings to compare yet.

EnterpriseHealthcare

At a glance

Lixte Biotechnology Holdings service facts
FactValue
Official sitehttps://lixtebiotechnology.com
Status coveragePublic status page
Founded2005
HeadquartersEast Setauket, New York, United States
CategoriesEnterprise, Healthcare
Loading offerings...